Background
The International Agency for Research on Cancer (IARC) has classified two of the tobacco-specific nitrosamines (TSNAs) – NNK and NNN – as group 1 carcinogens. The U.S. Food and Drug Administration has identified both compounds as harmful or potentially harmful constituents (HPHCs).

During the past several decades, the tobacco industry has taken a number of measures to decrease both NNN and NNK in flue-cured Virginia and burley tobaccos.

These measures include:

Barn conversion – More than 30,000 barns in the United States were retrofitted from direct-fired systems to heat exchangers to lower levels of TSNA in flue-cured tobaccos. Heat exchangers do not expose tobacco to direct-fired gases that contribute to the formation of TSNAs during flue-curing.

Use of burley low-converter seed – Burley tobaccos contain considerably higher levels of nornicotine (a precursor to NNN) than flue-cured Virginia tobaccos. University of Kentucky LC Protocol developed a screening process to reduce the levels of nornicotine present in burley tobacco variety through selecting plants with less than 3% nornicotine relative to nicotine content prior to seed harvest.

Adoption of good agricultural practices from the University of Kentucky, North Carolina State University, Virginia Polytechnic Institute and State University and University of Tennessee.

And now, today, the introduction of ZYVERT® technology and seeds gives us even greater ability to further reduce the presence of NNN. Because ZYVERT® technology, a stable, seed-based solution, takes care of the root cause of the problem and minimizes conversion of nicotine to nornicotine, a precursor of NNN.

Research & Publications
Work over the last decade has produced a significant level of scientific and industry support for the capabilities of ZYVERT® technology and seed.
The Technology
ZYVERT® technology is a non-GMO technology that disables the function of genes that facilitate conversion of nicotine to nornicotine, the precursor of NNN.